Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Investing Cash Flow

3.3 / 5 stars · 78/120 Roast Me

LEMAITRE VASCULAR, INC. Investing Cash Flow

LEMAITRE VASCULAR, INC. (LMAT) reported Investing Cash Flow of -$24.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$11.08M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$13.12M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$16.82M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$27.45M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$64.94M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$200.12M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$24.71M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$10.37M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$11.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$24.20M
10-Q · filed 2026-08-05
-$41.02M
derived: sum of 3 quarters · filed 2026-08-05
-$68.47M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$13.12M
10-Q · filed 2026-05-06
-$29.95M
derived: sum of 2 quarters · filed 2026-05-06
-$57.39M
derived: sum of 3 quarters · filed 2026-05-06
-$73.74M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$16.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$44.27M
derived: sum of 2 quarters · filed 2026-02-26
-$60.62M
derived: sum of 3 quarters · filed 2026-08-05
-$64.94M
10-K · filed 2026-02-26
2025-09-30-$27.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$43.80M
derived: sum of 2 quarters · filed 2026-08-05
-$48.12M
10-Q · filed 2025-11-07
-$222.01M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$16.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$20.67M
10-Q · filed 2026-08-05
-$194.56M
derived: sum of 3 quarters · filed 2026-08-05
-$207.43M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$4.32M
10-Q · filed 2026-05-06
-$178.21M
derived: sum of 2 quarters · filed 2026-05-06
-$191.08M
derived: sum of 3 quarters · filed 2026-05-06
-$202.08M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$173.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$186.76M
derived: sum of 2 quarters · filed 2026-02-26
-$197.76M
derived: sum of 3 quarters · filed 2026-02-26
-$200.12M
10-K · filed 2026-02-26
2024-09-30-$12.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$23.87M
derived: sum of 2 quarters · filed 2025-11-07
-$26.23M
10-Q · filed 2025-11-07
-$28.49M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$11.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$13.36M
10-Q · filed 2025-08-06
-$15.63M
derived: sum of 3 quarters · filed 2026-02-26
-$25.48M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$2.36M
10-Q · filed 2025-05-08
-$4.62M
derived: sum of 2 quarters · filed 2026-02-26
-$14.47M
derived: sum of 3 quarters · filed 2026-02-26
-$24.11M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$2.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$12.11M
derived: sum of 2 quarters · filed 2026-02-26
-$21.75M
derived: sum of 3 quarters · filed 2026-02-26
-$24.71M
10-K · filed 2026-02-26
2023-09-30-$9.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
-$19.49M
derived: sum of 2 quarters · filed 2024-11-08
-$22.45M
10-Q · filed 2024-11-08
-$22.86M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$9.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$12.60M
10-Q · filed 2024-08-08
-$13.01M
derived: sum of 3 quarters · filed 2025-02-28
-$21.46M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$2.96M
10-Q · filed 2024-05-10
-$3.37M
derived: sum of 2 quarters · filed 2025-02-28
-$11.83M
derived: sum of 3 quarters · filed 2025-02-28
-$12.80M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$402.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$8.86M
derived: sum of 2 quarters · filed 2025-02-28
-$9.84M
derived: sum of 3 quarters · filed 2025-02-28
-$10.37M
10-K · filed 2025-02-28
2022-09-30-$8.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$9.43M
derived: sum of 2 quarters · filed 2023-11-07
-$9.97M
10-Q · filed 2023-11-07
-$17.21M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$973.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$1.51M
10-Q · filed 2023-08-08
-$8.76M
derived: sum of 3 quarters · filed 2024-02-29
-$60.12M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$536.00K
10-Q · filed 2023-05-09
-$7.78M
derived: sum of 2 quarters · filed 2024-02-29
-$59.15M
derived: sum of 3 quarters · filed 2024-02-29
-$60.55M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$7.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$58.61M
derived: sum of 2 quarters · filed 2024-02-29
-$60.02M
derived: sum of 3 quarters · filed 2024-02-29
-$61.08M
10-K · filed 2024-02-29
2021-09-30-$51.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$52.77M
derived: sum of 2 quarters · filed 2022-11-08
-$53.83M
10-Q · filed 2022-11-08
-$50.16M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$2.46M
10-Q · filed 2022-08-05
$1.21M
derived: sum of 3 quarters · filed 2023-03-01
$2.56M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$1.06M
10-Q · filed 2022-05-10
$2.61M
derived: sum of 2 quarters · filed 2023-03-01
$3.96M
derived: sum of 3 quarters · filed 2023-03-01
-$53.93M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$5.02M
derived: sum of 2 quarters · filed 2023-03-01
-$52.87M
derived: sum of 3 quarters · filed 2023-03-01
-$52.89M
10-K · filed 2023-03-01
2020-09-30$1.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$56.54M
derived: sum of 2 quarters · filed 2021-11-04
-$56.56M
10-Q · filed 2021-11-04
-$60.11M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$57.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$57.91M
10-Q · filed 2021-08-05
-$61.46M
derived: sum of 3 quarters · filed 2022-02-28
-$67.19M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$25.00K
10-Q · filed 2021-05-10
-$3.57M
derived: sum of 2 quarters · filed 2022-02-28
-$9.30M
derived: sum of 3 quarters · filed 2022-02-28
-$12.37M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$3.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$9.27M
derived: sum of 2 quarters · filed 2022-02-28
-$12.34M
derived: sum of 3 quarters · filed 2022-02-28
-$24.10M
10-K · filed 2022-02-28
2019-09-30-$5.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$8.80M
derived: sum of 2 quarters · filed 2020-11-06
-$20.55M
10-Q · filed 2020-11-06
-$19.30M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30-$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$14.83M
10-Q · filed 2020-08-06
-$13.57M
derived: sum of 3 quarters · filed 2021-03-12
-$17.29M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31-$11.76M
10-Q · filed 2020-05-08
-$10.50M
derived: sum of 2 quarters · filed 2021-03-12
-$14.22M
derived: sum of 3 quarters · filed 2021-03-12
-$18.29M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$2.47M
derived: sum of 2 quarters · filed 2021-03-12
-$6.53M
derived: sum of 3 quarters · filed 2021-03-12
-$7.05M
10-K · filed 2021-03-12
2018-09-30-$3.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$7.79M
derived: sum of 2 quarters · filed 2019-11-08
-$8.31M
10-Q · filed 2019-11-08
-$32.49M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$4.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$4.59M
10-Q · filed 2019-08-06
-$28.77M
derived: sum of 3 quarters · filed 2020-03-12
-$31.10M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$521.00K
10-Q · filed 2019-05-06
-$24.70M
derived: sum of 2 quarters · filed 2020-03-12
-$27.04M
derived: sum of 3 quarters · filed 2020-03-12
2017-12-31-$24.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$26.51M
derived: sum of 2 quarters · filed 2020-03-12
-$28.96M
10-K · filed 2020-03-12
2017-09-30-$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
-$4.78M
10-Q · filed 2018-11-02
2017-06-30-$2.44M
10-Q · filed 2018-08-06
2016-12-31-$17.21M
10-K · filed 2019-03-11
2013-12-31-$318.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$3.90M
derived: sum of 2 quarters · filed 2014-03-21
-$5.39M
derived: sum of 3 quarters · filed 2014-03-21
-$6.19M
10-K · filed 2014-03-21
2013-09-30-$3.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$5.08M
derived: sum of 2 quarters · filed 2013-11-07
-$5.87M
10-Q · filed 2013-11-07
-$10.40M
derived: sum of 4 quarters · filed 2014-03-21
2013-06-30-$1.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$2.29M
10-Q · filed 2013-08-09
-$6.82M
derived: sum of 3 quarters · filed 2014-03-21
-$6.97M
derived: sum of 4 quarters · filed 2014-03-21
2013-03-31-$795.00K
10-Q · filed 2013-05-08
-$5.33M
derived: sum of 2 quarters · filed 2014-03-21
-$5.48M
derived: sum of 3 quarters · filed 2014-03-21
-$5.68M
derived: sum of 4 quarters · filed 2014-03-21
2012-12-31-$4.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$4.68M
derived: sum of 2 quarters · filed 2014-03-21
-$4.89M
derived: sum of 3 quarters · filed 2014-03-21
-$5.20M
10-K · filed 2014-03-21
2012-09-30-$150.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$355.00K
derived: sum of 2 quarters · filed 2013-11-07
-$667.00K
10-Q · filed 2013-11-07
-$1.81M
derived: sum of 4 quarters · filed 2014-03-21
2012-06-30-$205.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$517.00K
10-Q · filed 2013-08-09
-$1.66M
derived: sum of 3 quarters · filed 2014-03-21
-$1.03M
derived: sum of 4 quarters · filed 2014-03-21
2012-03-31-$312.00K
10-Q · filed 2013-05-08
-$1.45M
derived: sum of 2 quarters · filed 2014-03-21
-$821.00K
derived: sum of 3 quarters · filed 2014-03-21
-$1.33M
derived: sum of 4 quarters · filed 2014-03-21
2011-12-31-$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$509.00K
derived: sum of 2 quarters · filed 2014-03-21
-$1.02M
derived: sum of 3 quarters · filed 2014-03-21
-$1.82M
10-K · filed 2014-03-21
2011-09-30$632.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$118.00K
derived: sum of 2 quarters · filed 2012-11-09
-$681.00K
10-Q · filed 2012-11-09
-$5.37M
derived: sum of 4 quarters · filed 2013-03-27
2011-06-30-$514.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
-$1.31M
10-Q · filed 2012-08-10
-$6.00M
derived: sum of 3 quarters · filed 2013-03-27
-$6.39M
derived: sum of 4 quarters · filed 2013-03-27
2011-03-31-$799.00K
10-Q · filed 2012-05-03
-$5.49M
derived: sum of 2 quarters · filed 2013-03-27
-$5.87M
derived: sum of 3 quarters · filed 2013-03-27
2010-12-31-$4.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27
-$5.07M
derived: sum of 2 quarters · filed 2013-03-27
-$5.24M
10-K · filed 2013-03-27
2010-09-30-$383.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$544.00K
10-Q · filed 2011-11-14
2010-06-30-$161.00K
10-Q · filed 2011-08-12
2009-12-31$2.18M
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77